BM
BMY
Market ClosedBristol-Myers Squibb Company
US
34.10K employees
CEO: Christopher S. Boerner
Founded: 1972
$54.00
+$0.00(+NaN%)
Market Cap
110.27B
Beta
0.24
52W Range
N/A
Dividend Yield
4.63%
Forecasting Analysis
AI-powered predictions and statistical risk modeling for short-term price movements
AI Insight:
Bristol-Myers Squibb's AI 30-day forecast is projecting slight downside risk with weak short-term momentum. Analyst consensus for 12 months shows strong coverage but wide disagreement, indicating uncertainty in long-term valuation. This divergence underscores a mixed risk profile with potential volatility.
Current Price
N/A
Last closing price
Price Prediction
Machine learning prediction based on historical price patterns
Period:
Analyst Price Target for BMY
Loading analyst price targets...
Wall Street Forecasts
Revenue Forecast
Past Growth
N/A
Based on Historical CAGR
Forward Growth
N/A
Projected CAGR
Analyst Accuracy
0%
Estimate Accuracy
Revenue Analysis
Comparison of Actual and Estimated Revenues
Loading chart data...
Revenue growth steady at 0.0%.
Operating Profitability Forecast
Past Growth
N/A
EBITDA Historical CAGR
Forward Growth
N/A
EBITDA Projected CAGR
Analyst Accuracy
0%
Estimate Accuracy
EBITDA Analysis
Comparison of Actual and Estimated EBITDA
Loading chart data...
EBITDA maintaining 0.0% trajectory.
Earnings Per Share Forecast
Past Growth
N/A
EPS Historical CAGR
Forward Growth
N/A
EPS Projected CAGR
Analyst Accuracy
0%
Estimate Accuracy
EPS Analysis
Comparison of Actual and Estimated Earnings Per Share
Loading chart data...
EPS growth stable around 0.0%.
Explore BMY
BMY in the Healthcare
Large Cap